Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Focal Dystonia
Interventions
DRUG

Botulinum toxin, type B

Diluted botulinum toxin (500 Units/0.1 ml) is injected to the affected muscle(s) through a hollow core needle using electromyographic guidance. Dosage according to muscle(s) and symptom severity. Injection occurs at first visit only, after neurological evaluation.

Trial Locations (1)

10032

Neurological Institute, 710 W. 168th Street, NI-1112, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Solstice Neurosciences

INDUSTRY

lead

Columbia University

OTHER